Trial Profile
A Phase II, Prospective, Randomized, Observer-masked, Parallel-group, Multi-center Study Assessing the Safety and Efficacy of Two Concentrations Compared to Placebo for the Treatment of Dry Eye Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2014
Price :
$35
*
At a glance
- Drugs DE 110 (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Santen Incorporated
- 02 May 2014 New trial record